Search

Geron Corp

Aperta

SettoreSettore sanitario

0.94 1.08

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

0.89

Massimo

0.97

Metriche Chiave

By Trading Economics

Entrata

-13M

-17M

Vendite

5.6M

57M

EPS

-0.02

Margine di Profitto

-29.019

Dipendenti

258

EBITDA

-16M

-12M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+330.57% upside

Dividendi

By Acuity

Utili prossimi

4 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-82M

739M

Apertura precedente

-0.14

Chiusura precedente

0.94

Geron Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 nov 2026, 21:09 UTC

Geron Corporation's shares advanced during Monday's trading session, recovering from earlier losses and reflecting a positive trend after recent declines.

30 ott 2026, 20:03 UTC

Geron Corporation shares fell sharply, continuing a three-day decline and reaching a notable low, remaining well below their 20-day moving average.

29 ott 2026, 20:07 UTC

News
Event

Wedbush maintains Outperform rating on Geron Corporation but lowers price target to $5; company discontinues Phase 3 IMpactMF trial for imetelstat.

28 ott 2026, 20:02 UTC

Social Media
Event
Macro Event
News

Geron Corporation's stock declined sharply after discontinuing its Phase 3 IMpactMF trial for imetelstat due to unlikely success in meeting primary survival endpoints.

27 ott 2026, 19:56 UTC

Geron Corporation is trading roughly flat, showing little change since Monday's close, and remains below its 20-day moving average.

26 ott 2026, 20:06 UTC

Geron Corp's shares advanced, building on previous gains.

23 ott 2026, 20:07 UTC

Geron Corp's shares are roughly flat, maintaining their position near Thursday's close amid broader market declines influenced by economic indicators and rising oil prices.

22 ott 2026, 23:46 UTC

In after-market trading, Geron Corp is advancing sharply, with a cumulative return of 3.57% since Thursday's close.

21 ott 2026, 23:41 UTC

Geron Corp shares advanced in after-market trading following Wednesday's close, briefly peaking before retracing slightly, but remain below their 20-day moving average.

20 ott 2026, 20:08 UTC

Geron Corp shares are trading higher, maintaining momentum amid a broader market trend with significant gains observed in regular trading hours.

19 ott 2026, 19:16 UTC

Geron Corp shares are advancing, reflecting broader market gains since Friday.

16 ott 2026, 23:06 UTC

Geron Corp shares advanced modestly higher in after-market trading on Friday.

15 ott 2026, 20:51 UTC

Geron Corp's shares advanced in after-market trading, rising notably from a low shortly after the close, reflecting stable performance within its one-month trading range.

14 ott 2026, 23:11 UTC

Geron Corp shares advanced in after-market trading, remaining modestly higher since Wednesday's close, despite earlier pulling back from a session high.

13 ott 2026, 20:01 UTC

Geron Corp shares are declining, remaining significantly below their 20-day moving average, with a cumulative return down since Monday's close.

12 ott 2026, 22:16 UTC

Geron Corp shares are trading lower in after-market hours, retracing from an earlier session peak and remaining below their 20-day moving average.

9 ott 2026, 19:45 UTC

Geron Corp shares are trading roughly flat, showing little change since Thursday's close and positioned below its 20-day moving average.

8 ott 2026, 23:10 UTC

Geron Corp's shares advanced in after-market trading, moving higher from a low to a high since Thursday's close.

6 ott 2026, 20:07 UTC

Geron Corp's shares fell sharply, reflecting broader market volatility, and remain significantly below their 20-day moving average amid a declining trend.

5 ott 2026, 20:06 UTC

Geron Corp's shares are advancing, recovering from earlier declines and trading higher throughout the morning, though settling near the lower end of their one-month range.

1 ott 2026, 20:07 UTC

Geron Corp shares fell sharply, continuing a downward trend and remaining below their 20-day moving average, near the lower end of their one-month range.

30 set 2026, 20:07 UTC

Geron Corp's shares are advancing, having closed higher since Tuesday, despite pulling back from an earlier session peak.

29 set 2026, 23:40 UTC

Geron Corp saw notable gains in after-market trading, reaching its highest point since Tuesday's close, though still below its 20-day moving average.

28 set 2026, 20:07 UTC

Geron Corp shares fell amid a broader market downturn, influenced by declines in major tech stocks and rising geopolitical tensions, reflecting increased volatility.

25 set 2026, 19:46 UTC

Geron Corp is trading higher, having peaked earlier before retracing, though it remains below its 20-day moving average amid broader market weakness.

24 set 2026, 20:07 UTC

Geron Corp is advancing during Thursday's trading session, having peaked in the mid-afternoon, although it remains below its 20-day moving average.

23 set 2026, 22:01 UTC

In after-market trading, Geron Corp has advanced notably, moving higher since Wednesday's close, despite being 11.49% below its 20-day moving average.

22 set 2026, 22:50 UTC

Geron Corp is advancing in after-market trading, recovering from earlier declines, though it remains below its 20-day moving average.

18 set 2026, 19:36 UTC

Geron Corp shares fell sharply, continuing a decline since Thursday and trading significantly below the 20-day moving average.

17 set 2026, 23:01 UTC

Geron Corp's shares rose in after-market trading, recovering from earlier losses to reach their highest level of the day since Thursday's close.

Confronto tra pari

Modifica del prezzo

Geron Corp Previsione

Obiettivo di Prezzo

By TipRanks

330.57% in crescita

Previsioni per 12 mesi

Media 4 USD  330.57%

Alto 5 USD

Basso 3 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Geron Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

4 ratings

3

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat